A new Waipapa Taumata Rau, University of ߣߣƵspin-out company, , is working to introduce a groundbreaking, non-invasive treatment for the eye disease keratoconus.
Keratoconus affects the cornea, the clear tissue that covers the front of the eye, causing the collagen in the cornea to break down, becoming thin, distorted and characteristically conical in shape. This leads to reduced and distorted vision, sensitivity to light and, in severe cases, tearing of the cornea.
Existing treatment for moderate cases involves surgery, with transplant required for severe cases. University of ߣߣƵresearchers led by Colin Green, a serial entrepreneur and professor emeritus, have discovered a far less invasive treatment, using simple eye drops to strengthen the cornea.